Free Trial
NASDAQ:PLSE

Pulse Biosciences (PLSE) Stock Price, News & Analysis

Pulse Biosciences logo
$14.80 -0.52 (-3.42%)
As of 07/3/2025 02:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Pulse Biosciences Stock (NASDAQ:PLSE)

Key Stats

Today's Range
$15.01
$15.42
50-Day Range
$14.80
$17.95
52-Week Range
$11.13
$25.00
Volume
99,122 shs
Average Volume
184,907 shs
Market Capitalization
$995.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pulse Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

PLSE MarketRank™: 

Pulse Biosciences scored higher than 15% of companies evaluated by MarketBeat, and ranked 2572nd out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pulse Biosciences.

  • Percentage of Shares Shorted

    19.44% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 12.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently increased by 2.08%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Pulse Biosciences does not currently pay a dividend.

  • Dividend Growth

    Pulse Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    19.44% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 12.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently increased by 2.08%, indicating that investor sentiment is decreasing.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Pulse Biosciences this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Pulse Biosciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $246,000.00 in company stock.

  • Percentage Held by Insiders

    71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Pulse Biosciences' insider trading history.
Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
See More Headlines

PLSE Stock Analysis - Frequently Asked Questions

Pulse Biosciences' stock was trading at $17.41 at the start of the year. Since then, PLSE shares have decreased by 15.0% and is now trading at $14.7960.

Pulse Biosciences, Inc (NASDAQ:PLSE) announced its quarterly earnings results on Thursday, May, 8th. The company reported ($0.25) earnings per share (EPS) for the quarter.
Read the conference call transcript
.

Pulse Biosciences (PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company acted as the underwriters for the IPO.

Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and Jabil (JBL).

Company Calendar

Last Earnings
5/08/2025
Today
7/04/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PLSE
Fax
N/A
Employees
140
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.58 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$700 thousand
Price / Cash Flow
N/A
Book Value
$1.87 per share
Price / Book
7.91

Miscellaneous

Free Float
19,173,000
Market Cap
$995.33 million
Optionable
Optionable
Beta
1.56
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:PLSE) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners